The japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation

Kazuteru Ohashi, Juichi Tanabe, Reiko Watanabe, Takeshi Tanaka, Hisashi Sakamaki, Atsuo Maruta, Shinichiro Okamoto, Nobuyuki Aotsuka, Kenji Saito, Miki Nishimura, Hakumei Oh, Michio Matsuzaki, Satoshi Takahashi, Shuji Yonekura

研究成果: Article査読

117 被引用数 (Scopus)

抄録

Hepatic veno-occlusive disease (VOD) is a common transplant-related complication of stem cell transplantation. There is no safe and proven therapy for established VOD, and attempts have focused on its prevention. Limited studies have suggested that prophylactic use of ursodeoxycholic acid (UDCA) reduced the incidence of VOD. To confirm the preventive effect of UDCA on VOD, we conducted a prospective, unblinded randomized, multicenter study of UDCA involving 132 patients who underwent stern cell transplantation for a variety of disorders. Sixty-seven patients were assigned to the UDCA-treated group, and 65 patients were assigned to the control group. The clinical characteristics of the two groups were similar with respect to primary diagnosis, age, sex, and baseline organ function. The preparative regimen and GVHD prophylaxis did not differ significantly between the two groups. UDCA was highly effective in preventing VOD, which occurred in only 3.0% in the UDCA-treated group, as opposed to 18.5% in the control group (P = 0.0043). There were no adverse effects attributable to UDCA. The initial promising report of a prophylactic effect of UDCA on VOD after stern cell transplantation was confirmed in this prospective study. (C) 2000 Wiley-Liss, Inc.

本文言語English
ページ(範囲)32-38
ページ数7
ジャーナルAmerican journal of hematology
64
1
DOI
出版ステータスPublished - 2000
外部発表はい

ASJC Scopus subject areas

  • 血液学

フィンガープリント

「The japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル